Kats A et al. |
Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. |
2016 |
J. Cell. Mol. Med. |
pmid:26987561
|
Moran CS et al. |
Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966276
|
Zhou QL et al. |
Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. |
2016 |
Mol Med Rep |
pmid:27357904
|
Cong Q et al. |
p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. |
2016 |
Stem Cell Reports |
pmid:26947973
|
Wang C et al. |
Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. |
2016 |
Med. Sci. Monit. |
pmid:26939934
|
Lin J et al. |
Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. |
2016 |
Nat Commun |
pmid:26923114
|
D'Abramo A et al. |
Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. |
2016 |
PLoS ONE |
pmid:26913505
|
Lu J et al. |
Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. |
2016 |
Exp. Biol. Med. (Maywood) |
pmid:26908571
|
Stuss M et al. |
Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. |
2016 |
Endokrynol Pol |
pmid:26884284
|
Theodoro LH et al. |
Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. |
2016 |
J. Periodont. Res. |
pmid:26750739
|
Alam I et al. |
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. |
2016 |
Endocrinology |
pmid:26584014
|
Mitchell JA et al. |
Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. |
2016 |
J. Bone Miner. Res. |
pmid:26572781
|
Liu G et al. |
Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. |
2016 |
Cell Tissue Res. |
pmid:26004143
|
Bergamini A et al. |
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. |
2016 |
Int J Med Sci |
pmid:28090190
|
Toffoli B et al. |
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. |
2016 |
Mediators Inflamm. |
pmid:28070143
|
Chen H et al. |
[Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. |
2016 |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
pmid:28070039
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|
Ugay L et al. |
Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. |
2016 |
Chin. Med. J. |
pmid:27411457
|
Pellegrini GG et al. |
Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. |
2016 |
Nutrients |
pmid:27409635
|
Nagy EE et al. |
High circulating osteoprotegerin levels are associated with non-zero blood groups. |
2016 |
BMC Cardiovasc Disord |
pmid:27387019
|
Zhang YY et al. |
Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. |
2016 |
Chin J Dent Res |
pmid:27379348
|
Songia P et al. |
Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. |
2016 |
J. Mol. Cell. Cardiol. |
pmid:27338002
|
Sasso GR et al. |
Elevated serum osteoprotegerin levels in women: friend or foe? |
2015 Nov-Dec |
Rev Assoc Med Bras (1992) |
pmid:26841162
|
Calasans-Maia MD et al. |
Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814461
|
Jianru YI et al. |
Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814456
|
SaÄŸlam M et al. |
Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. |
2015 Jan-Feb |
J Appl Oral Sci |
pmid:25760266
|
Esteghamati A et al. |
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. |
2015 Aug-Sep |
Arch Cardiovasc Dis |
pmid:26184866
|
Li B et al. |
Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. |
2015 |
Genet. Mol. Res. |
pmid:26782591
|
Morisawa T et al. |
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. |
2015 |
Int Heart J |
pmid:26549398
|
Beuselinck B et al. |
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. |
2015 |
Br. J. Cancer |
pmid:26528707
|
Rewiuk K and Grodzicki T |
Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. |
2015 |
Biomed Res Int |
pmid:26504794
|
Pesce Viglietti AI et al. |
Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. |
2015 |
Infect. Immun. |
pmid:26459511
|
Nemeth ZK et al. |
Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. |
2015 |
Sci Rep |
pmid:26459001
|
Yang H et al. |
A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. |
2015 |
Int J Clin Exp Pathol |
pmid:26191212
|
Pitari MR et al. |
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. |
2015 |
Oncotarget |
pmid:26160841
|
Hsu BG et al. |
High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. |
2015 |
Tohoku J. Exp. Med. |
pmid:26156285
|
Miao X et al. |
Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. |
2015 |
J Orthop Surg Res |
pmid:26148858
|
Bartosińska J et al. |
The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. |
2015 |
Mediators Inflamm. |
pmid:26146462
|
Bortolin RH et al. |
Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. |
2015 |
PLoS ONE |
pmid:25933189
|
Wei J et al. |
Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. |
2015 |
Mol Med Rep |
pmid:25891179
|
Su F et al. |
Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. |
2015 |
Stem Cell Res Ther |
pmid:25888745
|
Shen Y et al. |
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. |
2015 |
BMC Complement Altern Med |
pmid:25887296
|
Duan P et al. |
Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. |
2015 |
BMC Womens Health |
pmid:25884698
|
Warren JT et al. |
Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. |
2015 |
J. Cell. Biochem. |
pmid:25864714
|
Kim KR et al. |
15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. |
2015 |
PLoS ONE |
pmid:25859665
|
Son GY et al. |
Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. |
2015 |
J. Dent. Res. |
pmid:25595364
|
Oostra DR et al. |
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25575458
|
Majerczyk M et al. |
[Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. |
2015 |
Postepy Hig Med Dosw (Online) |
pmid:27259222
|
Fu Y et al. |
Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. |
2015 |
J. Vet. Sci. |
pmid:25549213
|